Cogent Biosciences, Inc.(COGT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

COGT Cogent Biosciences, Inc.

盘后交易 02-03 18:23:22 EST

37.28

-0.68

-1.79%

盘后37.28

+0.000.00%

16:20 EST

最高38.51	最低36.63	成交量101.40万
今开37.96	昨收37.96	日振幅4.94%
总市值57.23亿	流通市值53.31亿	总股本1.54亿
成交额3,786万	换手率0.71%	流通股本1.43亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"COGT","market":"US","secType":"STK","nameCN":"Cogent Biosciences, Inc.","latestPrice":37.28,"timestamp":1770152400000,"preClose":37.96,"halted":0,"volume":1013962,"hourTrading":{"tag":"盘后","latestPrice":37.28,"preClose":37.28,"latestTime":"16:20 EST","volume":27187,"amount":1013546.7750289999,"timestamp":1770153600453,"change":0,"changeRate":0,"amplitude":0.004292},"delay":0,"changeRate":-0.017913593256059002,"floatShares":142999640,"shares":153505600,"eps":-1.9359708,"marketStatus":"盘后交易","change":-0.68,"latestTime":"02-03 18:23:22 EST","open":37.96,"high":38.505,"low":36.63,"amount":37861631.073132,"amplitude":0.049394,"askPrice":38.02,"askSize":52,"bidPrice":33.43,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.9359708,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770166800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1522296000000,"exchange":"NASDAQ","adjPreClose":37.96,"preHourTrading":{"tag":"盘前","latestPrice":36,"preClose":37.96,"latestTime":"09:02 EST","volume":2,"amount":74.32,"timestamp":1770127347321,"change":-1.96,"changeRate":-0.051633,"amplitude":0.061117},"postHourTrading":{"tag":"盘后","latestPrice":37.28,"preClose":37.28,"latestTime":"16:20 EST","volume":27187,"amount":1013546.7750289999,"timestamp":1770153600453,"change":0,"changeRate":0,"amplitude":0.004292},"volumeRatio":0.634133,"impliedVol":0.8988,"impliedVolPercentile":0.6335},"requestUrl":"/m/hq/s/COGT/tweets","defaultTab":"tweets","newsList":[{"id":"1151108523","title":"Cogent Biosciences递交Bezuclastinib治疗非晚期系统性肥大细胞增多症的新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1151108523","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151108523?lang=zh_cn&edition=full","pubTime":"2025-12-30 21:05","pubTimestamp":1767099958,"startTime":"0","endTime":"0","summary":"Cogent Biosciences宣布，已正式提交Bezuclastinib用于治疗非晚期系统性肥大细胞增多症的新药申请。这一重要进展标志着该创新疗法向临床应用迈出关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","COGT"],"gpt_icon":0},{"id":"1161798638","title":"Cogent Biosciences公布Bezuclastinib在晚期系统性肥大细胞增多症患者中的Apex试验积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1161798638","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161798638?lang=zh_cn&edition=full","pubTime":"2025-12-08 20:37","pubTimestamp":1765197462,"startTime":"0","endTime":"0","summary":"Cogent Biosciences公布Bezuclastinib在晚期系统性肥大细胞增多症（Advsm）患者中的Apex试验积极顶线结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COGT","BK4505"],"gpt_icon":0},{"id":"1180478503","title":"Cogent Biosciences, Inc. - Bezuclastinib试验显示89%的患者骨髓肥大细胞减少≥50%","url":"https://stock-news.laohu8.com/highlight/detail?id=1180478503","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180478503?lang=zh_cn&edition=full","pubTime":"2025-12-08 20:33","pubTimestamp":1765197207,"startTime":"0","endTime":"0","summary":"Cogent Biosciences, Inc. - Bezuclastinib试验显示89%的患者骨髓肥大细胞减少≥50%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","COGT"],"gpt_icon":0},{"id":"1195943636","title":"Cogent Biosciences宣布提议同时公开发行2031年到期可转换高级票据和普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1195943636","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195943636?lang=zh_cn&edition=full","pubTime":"2025-11-11 05:02","pubTimestamp":1762808536,"startTime":"0","endTime":"0","summary":"Cogent Biosciences宣布提议同时公开发行2031年到期可转换高级票据和普通股","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","COGT","BK4139"],"gpt_icon":0},{"id":"1175488357","title":"Cogent Biosciences, Inc.：Wedbush将其评级从中性上调至跑赢大市；目标价格从13美元上调至38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175488357","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175488357?lang=zh_cn&edition=full","pubTime":"2025-11-10 23:10","pubTimestamp":1762787415,"startTime":"0","endTime":"0","summary":"Cogent Biosciences, Inc.：Wedbush将其评级从中性上调至跑赢大市；目标价格从13美元上调至38美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COGT","BK4505"],"gpt_icon":0},{"id":"1157727526","title":"Cogent Biosciences股份在盘前交易中上涨121%，因其联合药物在晚期试验中减缓癌症进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1157727526","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157727526?lang=zh_cn&edition=full","pubTime":"2025-11-10 21:15","pubTimestamp":1762780558,"startTime":"0","endTime":"0","summary":"Cogent Biosciences股份在盘前交易中上涨121%，因其联合药物在晚期试验中减缓癌症进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COGT","BK4505","BK4139"],"gpt_icon":0},{"id":"1150988897","title":"Cogent Biosciences公布Bezuclastinib高峰期III期临床试验在胃肠道间质瘤中的积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1150988897","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150988897?lang=zh_cn&edition=full","pubTime":"2025-11-10 20:01","pubTimestamp":1762776094,"startTime":"0","endTime":"0","summary":"Cogent Biosciences公布Bezuclastinib高峰期III期临床试验在胃肠道间质瘤中的积极结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","COGT"],"gpt_icon":0},{"id":"1195113584","title":"Cogent Biosciences, Inc.截至2025年9月30日现金、现金等价物及可交易证券为3.909亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195113584","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195113584?lang=zh_cn&edition=full","pubTime":"2025-11-03 22:03","pubTimestamp":1762178587,"startTime":"0","endTime":"0","summary":"Cogent Biosciences, Inc.截至2025年9月30日现金、现金等价物及可交易证券为3.909亿美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COGT","BK4505","BK4139"],"gpt_icon":0},{"id":"2575200905","title":"Cogent Biosciences, Inc.盘中异动 快速跳水5.25%报15.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575200905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575200905?lang=zh_cn&edition=full","pubTime":"2025-10-15 01:00","pubTimestamp":1760461216,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日01时00分，Cogent Biosciences, Inc.股票出现波动，股价快速下挫5.25%。Cogent Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。其相关个股中，Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Senti Biosciences, Inc.涨幅较大，Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为2800.12%、37.72%、37.14%，振幅较大的相关个股有Pmgc Holdings Inc.、Cdt Equity Inc C/Wts 22/09/2028、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为55.85%、38.33%、37.50%。Cogent Biosciences, Inc.公司简介：Cogent Biosciences Inc是一家生物技术公司，专注于为遗传定义的疾病开发精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101501001694c91d11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101501001694c91d11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["COGT","BK4505","BK4139"],"gpt_icon":0},{"id":"2557333622","title":"Cogent Biosciences, Inc.盘中异动 临近收盘大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557333622","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557333622?lang=zh_cn&edition=full","pubTime":"2025-08-05 03:40","pubTimestamp":1754336414,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日03时40分，Cogent Biosciences, Inc.股票出现异动，股价急速上涨5.00%。Cogent Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.61%。其相关个股中，Psyence Biomedical Ltd.、Bioxcel Therapeutics, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为7583.72%、1480.30%、1118.94%，振幅较大的相关个股有凯信远达、Psyence Biomedical Ltd.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为92.95%、84.21%、80.73%。Cogent Biosciences, Inc.公司简介：Cogent Biosciences Inc是一家生物技术公司，专注于为遗传定义的疾病开发精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805034015a474f4e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805034015a474f4e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["COGT","BK4505","BK4139"],"gpt_icon":0},{"id":"2518273740","title":"Cogent Biosciences, Inc.盘中异动 早盘快速下挫5.14%报6.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518273740","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518273740?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:34","pubTimestamp":1741617259,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时34分，Cogent Biosciences, Inc.股票出现异动，股价大幅跳水5.14%。Cogent Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3473.08%、737.01%、547.82%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.，振幅分别为41.36%、40.33%、40.24%。Cogent Biosciences, Inc.公司简介：Cogent Biosciences Inc是一家生物技术公司，专注于为遗传定义的疾病开发精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223419a26a3cb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223419a26a3cb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","COGT","BK4505"],"gpt_icon":0},{"id":"2517588467","title":"Cogent Biosciences(COGT.US)获Scotiabank首次覆盖，给予跑赢大盘评级, 目标价17.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517588467","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517588467?lang=zh_cn&edition=full","pubTime":"2025-03-08 06:32","pubTimestamp":1741386747,"startTime":"0","endTime":"0","summary":"Cogent Biosciences(COGT.US)获Scotiabank首次覆盖，给予跑赢大盘评级, 目标价17.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08063248605336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["COGT"],"gpt_icon":0},{"id":"2517192712","title":"Cogent Biosciences, Inc.盘中异动 股价大跌5.02%报7.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517192712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517192712?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:59","pubTimestamp":1741291182,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时59分，Cogent Biosciences, Inc.股票出现异动，股价大幅下跌5.02%。截至发稿，该股报7.29美元/股，成交量28.4949万股，换手率0.25%，振幅5.35%。Cogent Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.24%。Cogent Biosciences, Inc.公司简介：Cogent Biosciences Inc是一家生物技术公司，专注于为遗传定义的疾病开发精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307035942989eecbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307035942989eecbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","COGT"],"gpt_icon":0},{"id":"2517173928","title":"Cogent Biosciences, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517173928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517173928?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:42","pubTimestamp":1741200158,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日02时42分，Cogent Biosciences, Inc.股票出现波动，股价大幅上涨5.02%。Cogent Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.37%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Marker Therapeutics, Inc.涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为952.54%、306.39%、303.63%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Marker Therapeutics, Inc.，振幅分别为82.59%、54.27%、50.73%。Cogent Biosciences, Inc.公司简介：Cogent Biosciences Inc是一家生物技术公司，专注于为遗传定义的疾病开发精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306024239a2610cd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306024239a2610cd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","COGT","BK4505"],"gpt_icon":0},{"id":"1190107990","title":"异动解读 | Cogent Biosciences, Inc.盘中大跌5.05%,暂时原因不明","url":"https://stock-news.laohu8.com/highlight/detail?id=1190107990","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190107990?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:46","pubTimestamp":1741020385,"startTime":"0","endTime":"0","summary":"Cogent Biosciences, Inc.(COGT)今日盘中股价大跌5.05%,引发市场广泛关注。\n根据公开新闻报道,该股盘中出现大幅下跌,最低报7.15美元/股,振幅6.24%。但目前暂时没有明确的消息报道可以解释其股价下跌的具体原因。\n公司主要从事生物技术领域,为遗传定义的疾病开发精准疗法。其主要产品CGT9486是一种旨在抑制导致系统性肥大细胞增多症和晚期胃肠道间质瘤的KIT激酶突变的药物。目前有待进一步关注公司动向,以明确导致股价大幅波动的原因。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | Cogent Biosciences, Inc.盘中大跌5.05%,暂时原因不明","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["COGT"],"gpt_icon":0},{"id":"2516655976","title":"Cogent Biosciences, Inc.盘中异动 临近午盘股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516655976","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516655976?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:36","pubTimestamp":1741019794,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日00时36分，Cogent Biosciences, Inc.股票出现异动，股价快速下跌5.05%。Cogent Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为3884.93%、173.17%、141.71%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、90.70%、70.53%。Cogent Biosciences, Inc.公司简介：Cogent Biosciences Inc是一家生物技术公司，专注于为遗传定义的疾病开发精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304003635abe65a63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304003635abe65a63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","COGT","BK4139"],"gpt_icon":0},{"id":"2516379238","title":"Cogent Biosciences, Inc.盘中异动 大幅上涨5.15%报7.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516379238","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516379238?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:05","pubTimestamp":1740758738,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时05分，Cogent Biosciences, Inc.股票出现波动，股价大幅上涨5.15%。Cogent Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2134.68%、472.61%、355.99%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Bioxcel Therapeutics, Inc.，振幅分别为46.60%、43.95%、41.62%。Cogent Biosciences, Inc.公司简介：Cogent Biosciences Inc是一家生物技术公司，专注于为遗传定义的疾病开发精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000539a258194e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000539a258194e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","COGT"],"gpt_icon":0},{"id":"2514386166","title":"Cogent Biosciences, Inc.盘中异动 早盘大幅上涨5.22%报7.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514386166?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:50","pubTimestamp":1740667824,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时50分，Cogent Biosciences, Inc.股票出现波动，股价快速上涨5.22%。Cogent Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Pds Biotechnology Corporation、Nutriband Inc C/Wts 涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为472.71%、96.28%、85.32%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Biorestorative Therapies, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为59.93%、30.36%、21.99%。Cogent Biosciences, Inc.公司简介：Cogent Biosciences Inc是一家生物技术公司，专注于为遗传定义的疾病开发精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272250259632b4e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272250259632b4e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["COGT","BK4505","BK4139"],"gpt_icon":0},{"id":"2514740861","title":"Cogent Biosciences, Inc.盘中异动 急速下跌5.01%报6.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514740861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514740861?lang=zh_cn&edition=full","pubTime":"2025-02-27 03:29","pubTimestamp":1740598157,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日03时29分，Cogent Biosciences, Inc.股票出现异动，股价快速跳水5.01%。Cogent Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6547.79%、305.81%、259.14%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为194.07%、81.11%、54.00%。Cogent Biosciences, Inc.公司简介：Cogent Biosciences Inc是一家生物技术公司，专注于为遗传定义的疾病开发精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270329179893e051&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270329179893e051&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","COGT","BK4139"],"gpt_icon":0},{"id":"2514130920","title":"Cogent Biosciences, Inc.盘中异动 急速下挫5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514130920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514130920?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:18","pubTimestamp":1740496739,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时18分，Cogent Biosciences, Inc.股票出现波动，股价急速跳水5.09%。Cogent Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1052.14%、848.17%、586.47%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp，振幅分别为121.95%、63.66%、61.16%。Cogent Biosciences, Inc.公司简介：Cogent Biosciences Inc是一家生物技术公司，专注于为遗传定义的疾病开发精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231859a25392d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231859a25392d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["COGT","BK4505","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cogentbio.com","stockEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":0.0927},{"period":"3month","weight":1.6865},{"period":"6month","weight":2.4603},{"period":"1year","weight":3.0773},{"period":"ytd","weight":0.0687}],"compareEarnings":[{"period":"1week","weight":0.0039},{"period":"1month","weight":0.0179},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.099},{"period":"1year","weight":0.1555},{"period":"ytd","weight":0.0198}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cogent Biosciences, Inc.成立于特拉华州。该公司是一家生物技术公司，致力于开发针对遗传疾病的精准疗法。Cogent最先进的产品PLX9486是一种高度选择性的酪氨酸激酶抑制剂，旨在有效抑制KIT D816V突变以及KIT外显子17中的其他突变。KITD816V会引发罕见的严重疾病，称为系统性肥大细胞增多症。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.010222},{"month":2,"riseRate":0.25,"avgChangeRate":-0.011941},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.056596},{"month":4,"riseRate":0.25,"avgChangeRate":-0.063724},{"month":5,"riseRate":0.625,"avgChangeRate":0.053167},{"month":6,"riseRate":0.625,"avgChangeRate":0.137381},{"month":7,"riseRate":0.75,"avgChangeRate":0.693474},{"month":8,"riseRate":0.625,"avgChangeRate":0.126132},{"month":9,"riseRate":0.375,"avgChangeRate":-0.11087},{"month":10,"riseRate":0.5,"avgChangeRate":-0.011089},{"month":11,"riseRate":0.125,"avgChangeRate":0.046358},{"month":12,"riseRate":0.25,"avgChangeRate":-0.095771}],"exchange":"NASDAQ","name":"Cogent Biosciences, Inc.","nameEN":"Cogent Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cogent Biosciences, Inc.(COGT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cogent Biosciences, Inc.(COGT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cogent Biosciences, Inc.,COGT,Cogent Biosciences, Inc.股票,Cogent Biosciences, Inc.股票老虎,Cogent Biosciences, Inc.股票老虎国际,Cogent Biosciences, Inc.行情,Cogent Biosciences, Inc.股票行情,Cogent Biosciences, Inc.股价,Cogent Biosciences, Inc.股市,Cogent Biosciences, Inc.股票价格,Cogent Biosciences, Inc.股票交易,Cogent Biosciences, Inc.股票购买,Cogent Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cogent Biosciences, Inc.(COGT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cogent Biosciences, Inc.(COGT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}